- Report
- August 2023
- 141 Pages
Global
From €5297EUR$5,500USD£4,555GBP
- Report
- March 2023
- 280 Pages
Global
From €4621EUR$4,799USD£3,975GBP
- Report
- May 2018
- 140 Pages
Global
From €3371EUR$3,500USD£2,899GBP
- Report
- June 2021
- 77 Pages
Global
From €4767EUR$4,950USD£4,100GBP
- Report
- September 2020
- 108 Pages
Global
From €3852EUR$4,000USD£3,313GBP
- Report
- November 2021
- 802 Pages
Global
From €4815EUR$5,000USD£4,141GBP
- Book
- May 2024
- 464 Pages
The Nucleic Acid Delivery market is a subset of the Genomics industry, focusing on the development and delivery of nucleic acid-based products. These products are used in a variety of applications, such as gene therapy, gene editing, and gene regulation. Nucleic acid delivery technologies are used to deliver genetic material into cells, allowing for the manipulation of gene expression and the development of new treatments for genetic diseases.
Nucleic acid delivery technologies are also used in research and development, allowing scientists to study the effects of genetic manipulation on cells and organisms. This technology is also used in the development of diagnostics and therapeutics, as well as in the production of biologics.
Companies in the Nucleic Acid Delivery market include BioNTech, Moderna, Inovio Pharmaceuticals, and Cellectis. These companies are involved in the development and delivery of nucleic acid-based products, as well as in the research and development of new treatments and diagnostics. Show Less Read more